Epirubicin loaded on magnetite-coated calcium ferrite conjugated folic acid (Fe3O4@CaFe2O4-FA@EPI) was synthesized and characterized using various techniques like SEM, EDX, FT-IR, XRD, TGA, BET, and VSM. Also, the therapeutic effects on A-549 and A-431 cancer cell lines and delivering ability of Fe3O4@CaFe2O4-FA@EPI for potential use as a system of targeted drug delivery in cancer therapy were investigated. The obtained results show that these hybrid nanoscale particles have a large capacity of adsorption for EPI (19.4 wt.%) and desirable drug loading performance (97.5%). The acetate buffer environment guides the drug release to a higher amount (99%), in comparison with the phosphate-buffered saline (28%). Also, the Fe3O4@CaFe2O4-FA@EPI nanohybrids in vitro cytotoxic activity versus A-549 (null folate receptor) and A-431 (positive folate receptor) cancer cell lines in group III (Fe3O4@EPI) investigations, show the higher cell cytotoxicity and apoptosis in A-549 cells compared to A-431 (p < 0.05). Moreover, in A-431 cells, the percent of cell cytotoxicity and cell death grew in the Fe3O4@CaFe2O4-FA@EPI group in comparison with the A-549 cell line (p < 0.05). The results illustrated the effects of Fe3O4@CaFe2O4-FA@EPI group on cytotoxicity and apoptosis of A-431 positive folate receptor cancer cells were almost two times greater than free EPI. Furthermore, obtained findings show that the Fe3O4@CaFe2O4-FA@EPI provides a specific growth inhibition of cancer cells through binding to receptors on the cell membrane and intracellular uptake.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
M. Prasad, U.P. Lambe, B. Brar, I. Shah, J. Manimegalai, K. Ranjan, R. Rao, S. Kumar, S. Mahant, S.K. Khurana, Biomed. Pharmacother. 97, 1521 (2018)
F. Nemati, A. Elhampour, Res. Chem. Intermed. 42, 10 (2016)
L. Khanna, N. Verma, Mater. Lett. 128, 376 (2014)
Y. Patil, Y. Amitay, P. Ohana, H. Shmeeda, A. Gabizon, J. Control Release 225, 87 (2016)
A.U. Buzdar, N.K. Ibrahim, D. Francis, D.J. Booser, E.S. Thomas, R.L. Theriault, L. Pusztai, M.C. Green, B.K. Arun, S.H. Giordano, J. Clin. Oncol. 23, 16 (2005)
N. Kandpal, N. Sah, R. Loshali, R. Joshi. J. Prasad. J. Sci. Ind. Res. 73, (2014)
A. Debnath, A. Bera, K. Chattopadhyay, B. Saha, AIP Conf. Proc 1731, 050103 (2016)
W. Cheng, J. Nie, L. Xu, C. Liang, Y. Peng, G. Liu, T. Wang, L. Mei, L. Huang, X. Zeng, ACS Appl. Mater. Interfaces 9, 22 (2017)
S. Gatti, A. Agostini, U.C. Palmiero, C. Colombo, M. Peviani, A. Biffi, D. J. Nanotechnol. 29, 30 (2018)
S. Lee, J.A. Kwon, K.H. Park, C.M. Jin, J.B. Joo, I. Choi, Eur. J. Pharm. Biopharm. 131, 232 (2018)
R. Foldbjerg, D.A. Dang, H. Autrup, Arch. Toxicol. 85, 7 (2011)
M. Ono, A. Hirata, T. Kometani, M. Miyagawa, S.-I. Ueda, H. Kinoshita, T. Fujii, M. Kuwano, Mol. Cancer. Ther. 3, 4 (2004)
K. Ghosh, K. Chandra, A.K. Ojha, S. Sarkar, S.S. Islam, Carbohydr. Res. 344, 5 (2009)
R.C. Borra, M.A. Lotufo, S.M. Gagioti, F.D.M. Barros, P.M. Andrade, Braz. Oral. Res. 23, 3 (2009)
S.M. Smith, M.B. Wunder, D.A. Norris, Y.G. Shellman, PLoS ONE 6, 11 (2011)
M. Kadyrov, C. Schmitz, S. Black, P. Kaufmann, B. Huppertz, Placenta 24, 5 (2003)
M. Aghazadeh, Mater. Lett. 211, 225 (2018)
R. Bilas, K. Sriram, P.U. Maheswari, K.M.S. Begum, Int. J. Biol. Macromol. 97, 513 (2017)
H.B. Lakshmi, B. Madhu, M. Veerabhadraswamy, Int. J. Eng. Res. Adv. Tech. 3, 21 (2017)
D.R. Babu, K. Venkatesan, J. Crys. Growth. 468, 179 (2017)
Y. Zhu, C. Peng, Z.-F. Gao, H. Yang, W.-M. Liu, Z.-J. Wu, J. Environ. Chem. Eng. 6, 2 (2018)
N. Kumar, A. Kumar, S. Chandrasekaran, T.Y. Tseng, J. O. C. E. T. 6, 1 (2018)
B. Zamani-Ranjbar-Garmroodi, M.A. Nasseri, A. Allahresani, K. Hemmat, Res. Chem. Intermed. 45, 11 (2019)
M. Bagherzadeh, R. Kaveh, Photochem. Photobiol. 359, 11 (2018)
E. Farzad, H. Veisi, J. Ind. Eng. Chem. 60, 114 (2018)
P. Balasubramanian, R. Settu, S.-M. Chen, T.-W. Chen, G. Sharmila, J. Colloid Interface Sci. 524, 417 (2018)
M. Rostami, M. Aghajanzadeh, M. Zamani, H.K. Manjili, H. Danafar, Res. Chem. Intermed. 44, 3 (2018)
N. Sulaiman, M. Ghazali, B. Majlis, J. Yunas, M. Razali, Bio-Med. Mater. Eng. 26, s1 (2015)
L. Khanna, N.K. Verma, Phys. B Condens. Matter 427, 68 (2013)
S. Xuan, X. Lv, C. Ding, K. Tang, G. Li, G. Pei, S. Wu, Steel. Res Int. 89, 5 (2018)
Y. You, H. Zhao, G.F. Vance, Colloids Surf. A 205, 3 (2002)
I. Clark, P.W. Dunne, R.L. Gomes, E. Lester, J. Colloid. Interface Sci. 504, 492 (2017)
Q. Chen, J. Zheng, X. Yuan, J. Wang, L. Zhang, Mater. Sci. Eng. C. 82, 1 (2018)
Y. Salinas, C. Hoerhager, A. García-Fernández, M. Resmini, F.L. Sancenón, R.N. Matínez-Máñez, O. Brueggemann, ACS Appl. Mater. Interfaces 10, 34029 (2018)
B. Balraj, N. Senthilkumar, C. Siva, R. Krithikadevi, A. Julie, I.V. Potheher, M. Arulmozhi, Res. Chem. Intermed. 43, 4 (2017)
M. Jayapriya, K. Premkumar, M. Arulmozhi, K. Karthikeyan, Res. Chem. Intermed. 4, 1 (2020)
Z. Izadiyan, K. Shameli, M. Miyake, S.Y. Teow, S.C. Peh, S.E. Mohamad, S.H. Taib, Mater. Sci. Eng. C. 1, 96 (2019)
A. Yassemi, S. Kashanian, H. Zhaleh, Pharm. Dev. Technol. 25(4), 397 (2020)
N. Shahabadi, M. Razlansari, H. Zhaleh, K. Mansouri, Mater. Sci. Eng. C 1, 101 (2019)
S. Kamaraj, U.M. Palanisamy, M.S.B.K. Mohamed, A. Gangasalam, G.A. Maria, R. Kandasamy, Eur. J. Pharm. Sci. 116, 48 (2018)
W. Lin, Y.-W. Huang, X.-D. Zhou, Y. Ma, Toxicol. Appl. Pharmacol. 217, 3 (2006)
F. Sambale, S. Wagner, F. Stahl, R. Khaydarov, T. Scheper, D. Bahnemann, J. Nanomater. 16, 1 (2015)
The Razi University Research Center's financial support is gratefully acknowledged.
Conflict of interest
The researchers declare they do not have any conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shahabadi, N., Razlansari, M., Khorshidi, A. et al. Investigation of controlled release properties and anticancer effect of folic acid conjugated magnetic core–shell nanoparticles as a dual responsive drug delivery system on A-549 and A-431 cancer cell lines. Res Chem Intermed 46, 4257–4278 (2020). https://doi.org/10.1007/s11164-020-04205-9
- Calcium ferrite
- Folic acid
- Targeted drug delivery